论文部分内容阅读
目的 :探讨分析肾康注射液联合黄葵胶囊治疗小儿急性肾小球肾炎蛋白尿的临床效果。方法 :选取在我院接受治疗的急性肾小球肾炎患儿122例作为研究对象,按照治疗方法将其分为黄葵组与肾康组,每组各61例,黄葵组采用肾康注射液联合黄葵胶囊治疗,肾康组采用肾康注射液治疗,治疗结束后,对比分析两组患儿的治疗效果。结果 :通过对比发现,黄葵组患儿的治疗效果高于肾康组,两组差异明显,具有统计学意义(P<0.05)。结论 :肾康注射液联合黄葵胶囊治疗急性肾小球肾炎蛋白尿的疗效显著,可有效地降低蛋白尿等指标,值得临床推广应用。
Objective: To investigate the clinical effect of Shenkang injection combined with Huang Kui capsule in treating children with acute glomerulonephritis proteinuria. Methods: A total of 122 children with acute glomerulonephritis who were treated in our hospital were selected as research objects. According to the treatment methods, they were divided into Huang Kui group and Shenkang group, each group had 61 cases. Huang Kui group was treated with Shenkang injection Liquid combined with Huang Kui capsule treatment, Shen Kang group with Shen Kang injection treatment, after treatment, comparative analysis of the treatment of children in both groups. Results: The results showed that the treatment effect of Huangkui group was higher than that of Shenkang group, with significant difference between the two groups (P <0.05). Conclusion: Shenkang injection combined with Huang Kui capsule treatment of acute glomerulonephritis proteinuria significant effect, can effectively reduce the proteinuria and other indicators, worthy of clinical application.